| AMPK | AMPc-activated protein kinase |
| CI | confidence interval |
| COX-2 | cyclooxygenase 2 |
| CRC | colorectal cancer |
| ERK | extracellular signal-regulated kinase |
| HCC | hepatocellular carcinoma |
| HGD | high grade dysplasia |
| IBD | inflammatory bowel disease |
| IGF | insulin growth factors |
| IL | interleukin |
| IR | insulin resistance |
| LT | liver transplant |
| MAMPs | microorganism-associated molecular patterns |
| MAPK | mitogen-activated protein kinase |
| MetS | metabolic syndrome |
| mTOR | mammalian target of rapamycin |
| NAFL | non-alcoholic fatty liver |
| NAFLD | non-alcoholic fatty liver disease |
| NASH | non-alcoholic steatohepatitis |
| NF-kB | nuclear factor-κ B |
| OR | odds ratio |
| PGE2 | Prostaglandin E2 |
| RR | relative risk |
| SIR | standardized incidence ratio |
| STAT3 | signal transducer and activator of transcription |
| TNF-α | tumor necrosis factor α |
| US | ultrasound |
| JAK2 | Janus kinase-2 |